Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
This Outlook takes a look at conditions that affect only women, or more women than men, as well as those with different symptoms in the sexes. It discusses how to meet the challenges in conducting research in patriarchal societies in Africa; explains why research on sexual arousal in women has finally become a priority; and questions whether girls are entering puberty earlier — and, if so, whether we should be worried.
Free full access
To read more on the effect of X chromosomes, visit nature.com, see: go.nature.com/2xm9luk
For more on the dearth of women in clinical trials, visit: go.nature.com/2yjnzIx
This Nature Outlook is editorially independent, produced with financial support from a third party.
About
this content.
Surveys of the microbes that live in the vagina have revealed unexpected variability. More research might reveal links between these microbes, infection and birth complications.
Regulators have been calling for equal representation of men and women in health research for nearly 25 years. So why are women still underrepresented?
There is only one industrialized country where the rate of maternal deaths has risen over the past 30 years. US researchers are trying to find out what went wrong.
Clinical practice regarding the use of hormone-replacement therapy (HRT) has undergone many changes since its introduction in the 1940s. Here, Roger Lobo frames the current thinking on the use of HRT in postmenopausal women, beginning with a historical perspective and then discussing how the interpretation of HRT data has changed over time.
John Perry, Ken Ong and colleagues analyze genotype data on ∼370,000 women and identify 389 independent signals that associate with age at menarche, implicating ∼250 genes. Their analyses suggest causal inverse associations, independent of BMI, between puberty timing and risks for breast and endometrial cancers in women and prostate cancer in men.
The prevalence of stroke in women is predicted to increase rapidly in the near future. Yet, despite the presence of numerous female-specific risk factors for stroke, women remain under-represented in stroke clinical trials. Here, members of the Women Initiative for Stroke in Europe (WISE) group summarize new advances and future research priorities in the research of stroke in women.
Charlotte Cordonnier
Nikola Sprigg
the Women Initiative for Stroke in Europe (WISE) group
Women's health is more than reproductive health. Why does this phrase still need to be repeated? This commentary highlights the urgent need to encourage more women to lead, research, and educate to move beyond stereotypes and to ensure we push forward in improving the lives of women everywhere.
Whole-genome shotgun sequencing and sequencing of the gene encoding the 16S rRNA in samples from a variety of body sites in a large cohort of mothers and their infants reveals that, during the 6 weeks after birth, changes in the composition and function of the microbiome are driven by body site but not by the mode of delivery.
Menopause is the age-related loss of female reproductive function. Here, Davis et al. describe menopause physiology and its impact on women's health. They call for more research to understand the basic biology underlying this transition and to develop new therapies.
Menopause is the age-related (primary) or iatrogenic (secondary) loss of female reproductive function. Menopausal women are at increased risk for many conditions including cardiovascular disease, osteoporosis and some cancers, by mechanisms that are not yet fully understood.